Search for: "In Re: M.D. and S.D."
Results 201 - 220
of 248
Sorted by Relevance
|
Sort by Date
31 Jan 2017, 12:14 pm
M.D. [read post]
7 Dec 2021, 8:44 am
Defendants accused (perhaps wrongly) of serious misconduct Many defendants could be ruined simply by being publicly accused of certain offenses (rape, sexual harassment, embezzlement, fraud, malpractice, and the like)—or can be materially harmed even by being sued for more minor matters, such as in landlords' unlawful detainer actions against tenants. [1] Even if they know they're innocent, they might agree to settle as a means of avoiding the lawsuit even being filed, thus… [read post]
13 Sep 2009, 7:24 pm
Supp. 2d 339, 348 (M.D. [read post]
15 Apr 2011, 6:02 am
Bristol-Myers Squibb, 1998 WL 812318, at *46 (M.D. [read post]
2 Jun 2011, 12:46 pm
Supp.2d 980, 984 (M.D. [read post]
27 Dec 2011, 9:56 am
I reference the pharmaceutical company defense lawyers from Dechert at Drug & Device Law a lot here on this blog even though, as a plaintiff’s lawyer, I’m always on the other side from them (one might even say they’re on the wrong side of the law) because they write a great blog. [read post]
21 Apr 2010, 12:08 pm
So those three are all we’re discussing today – three, no more, no less. [read post]
3 May 2016, 5:08 pm
Stephen O’Donnell Cyber liability insurance is a relatively new product and many of the terms and conditions found in cyber-liability policies are as yet untested in the courts. [read post]
20 Mar 2009, 2:05 am
App. 1971); In re Guidant Corp. [read post]
27 Aug 2010, 2:41 pm
In the last month, we’ve seen two more appellate decisions definitively rejecting the idea of some sort of separate cause of action – apart from warning or design defect – for “failure to test,” whatever that might be. [read post]
7 May 2012, 5:00 am
Sherwood Medical Industries, 836 F.2d 296, 302-303 (7th Cir. 1987); In re Zyprexa Products Liability Litigation v. [read post]
6 Jan 2020, 7:53 am
Lewis, 2018 WL 3008008 (M.D. [read post]
4 Jan 2017, 7:09 pm
., 2:14-cv-02164-EAS-TPK, (S.D. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
3 Feb 2011, 2:11 pm
Supp. 33, 35 (M.D. [read post]
7 Jun 2020, 1:17 am
Requirements Imposed By State Licensing Boards and Medical Professional Societies The involvement of medical professionals in disciplining physicians for dubious litigation testimony, whether through state licensing authorities or voluntary medical associations, raises some difficult questions: Does a physician’s rendering an opinion on a medical issue in litigation, such as diagnosing silicosis, asbestosis, welding-induced encephalopathy, or fenfluramine-related cardiac injury, constitute the… [read post]
10 Dec 2015, 2:00 am
, No. 2:14-cv-16744, 2015 WL 5786771 (S.D. [read post]
24 Jan 2014, 12:57 am
In many jurisdictions, corporate officials sued for their actions undertaken in their corporate capacity may be able to defend themselves in reliance on the “business judgment rule. [read post]
29 Jul 2010, 5:00 am
Supp.2d 1270, 1283-84 (M.D. [read post]
